We find that oncogenic NRAS, KRAS, and HRAS activate the expression of IkappaBalpha (IκBα) and BAY 11-7082, an inhibitor of IκBα kinase, attenuates the growth of NRAS, KRAS, and HRAS mutant cancer cells in cell culture and in vivo mouse model. This evidence concerns the gene KRAS and cancer.